Forward Stock Split

Canadian clinical-stage psychedelics developer Algernon Pharmaceuticals Inc. (OTCQB: AGNPF) will start trading its Class A common shares following a 4-to-1 stock split towards increasing liquidity.  Effective as of market opening on March 3, 2023, the upcoming reorganization will consist of...